Skip to search.
 TSX Up 0.17% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Novavax, Inc. (NVAX)

-NasdaqGS
4.21 Down 0.10(2.43%) 11:54AM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:4.31
Open:4.34
Bid:4.22 x 2000
Ask:4.23 x 2300
1y Target Est:11.20
Beta:1.17
Earnings Date:May 5 - May 9 (Est.)
Day's Range:4.07 - 4.36
52wk Range:1.68 - 6.95
Volume:1,217,655
Avg Vol (3m):4,804,660
Market Cap:877.34M
P/E (ttm):N/A
EPS (ttm):-0.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.43%877.34M
MRKDown 0.55%168.94B
NVSDown 0.02%209.95B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):42.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.31
Quarterly EPS Est (Mar-14) :-0.07
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback